In comparison to breast cancers in which there was a strong correlation between ERBB2 mRNA and HER2 protein levels (cor = 0.79, p < 0.001), this association was weaker in urothelial cancers (cor = 0.72, p < 0.001) (Supplementary Fig. 3C). Here, ERBB2 is linked to breast carcinoma.